ERBB2 and colorectal carcinoma: The overexpression of HER2, found in approximately 47.4% of CRC patients, has been associated with a negative prognosis.52 HER2’s activation primarily impacts cellular differentiation, proliferation, and the apoptotic process within CRC cells.